Empirical Ventures
To add a bio or update investment portfolio, please click update information.
Investment Portfolio
Nuclear Turbines raises £15m led by IQ Capital to develop compact, low-cost advanced nuclear power systems
Nuclear Turbines develops compact, advanced nuclear power systems that pair a novel reactor design with high-temperature turbine technology of the kind used in jet engines and gas-fired power plants. Built to run without steam infrastructure, the systems are small enough to be deployed behind the meter at industrial sites and data centres.
Healome Therapeutics raises £2m to advance eye-drop matrix technology treating dry eye and ocular surface disease
Healome Therapeutics is a University of Birmingham spinout developing an eye-drop matrix technology that extends the residence time of therapeutics on the ocular surface. The platform is designed for use in dry eye disease, ocular surface inflammation, corneal injury and rare diseases causing severe ocular surface damage.
Neuronostics raises £3m in funding led by Empirical Ventures and The FSE Group for platform that diagnoses epilepsy from brain activity recordings
Neuronostics develops BioEP, a digital biomarker platform that analyses EEG recordings to support the diagnosis and prognosis of epilepsy. The platform is designed for clinicians who need objective decision support when routine EEG results are inconclusive.
Silveray lands £5m Series A led by PXN Ventures to scale ultra-thin flexible X-ray film technology
Silveray has developed a flexible Digital X-ray Film (DXF®) that produces high-quality radiographic images using ultra-thin, lightweight detectors that can conform to curved surfaces. The technology is designed to replace conventional rigid X-ray detectors in both industrial inspection and medical imaging applications.
Optera raises £3m in funding led by Future Planet Capital to track fast-moving objects in space with neuromorphic sensors
Optera develops neuromorphic, event-based sensors and AI analytics that detect, track and characterise high-velocity objects in space. Its architecture captures only changes in a scene rather than full frames, reducing data and power requirements and enabling persistent operations on the ground and in orbit.
Caudal Energy raises £4.3m in funding led by Oxford Science Enterprises and Empirical Ventures to develop predictable tidal power technology
Caudal Energy develops fin-based tidal power systems designed to generate predictable renewable electricity from mid-flow tidal sites. The Oxford spinout is building modular infrastructure intended to reduce deployment complexity and expand where tidal energy can be commercially viable.
Fermtech raises a £2.5m seed round led by Elbow Beach to scale production of sustainable cocoa alternative
Fermtech is a biotechnology company developing fermentation technology to turn agricultural byproducts into food ingredients. Its Koji Cocoa™ product converts cocoa shells into a cocoa alternative for food manufacturers to reduce costs and environmental impact.
Orthofuse secures a £2.2m seed round from angels and VCs for 3D-printed orthopaedic implant systems
Orthofuse develops 3D-printed orthopaedic implant systems for complex trauma and spinal procedures. Its designs aim to simplify insertion and improve fixation in challenging surgical cases.
QV Bioelectronics raises £4.5m in funding led by PXN Ventures to treat brain cancer with implantable device
QV Bioelectronics develops an implantable medical device that delivers therapeutic electric fields to residual brain cancer cells, aiming to reduce tumour regrowth following surgery for patients with glioblastoma.
OutSee completes its £2.5m seed round led by Ahren Innovation Capital for its genomic drug discovery platform
OutSee develops AI-driven genomics software that identifies disease targets directly from genetic data, supporting drug discovery by uncovering biological mechanisms missed by conventional analysis methods.
BoobyBiome secures £2.5m seed round led by Empirical Ventures to advance breast milk microbiome tech
BoobyBiome develops technology that preserves the microbiome of breast milk and supports infant gut health, including specialised storage solutions and live microbiome supplements.
EnsiliTech raises £4.5m seed round led by Eos Advisory to transform global medicine storage and transport
EnsiliTech develops technology that stabilises vaccines and biologics at high temperatures, removing the need for cold-chain storage and improving global access to medicines.
OutSee raises £1.8m seed round led by Ahren Innovation Capital to advance AI-driven genomic target discovery
OutSee builds a predictive genomics platform that uses hypothesis-free AI modelling to discover new therapeutic targets, supporting precision medicine across neurological, rare and metabolic diseases.
OSSTEC raises £2.5m in funding led by Empirical Ventures to bring 3D-printed knee implants to market
OSSTEC develops 3D-printed knee implants that replicate cartilage and bone structures, aiming to reduce complications and improve outcomes in joint replacement surgery through less invasive, patient-specific implant design.
Exciting Instruments raises £4m seed led by Northern Gritstone to revolutionise single-molecule detection for drug discovery
Exciting Instruments develops a single-molecule detection platform that makes advanced microscopy more accessible, enabling researchers and pharmaceutical teams to analyse individual molecules at scale for drug discovery and diagnostics.
X-ray technology innovator Silveray lands £4m seed led by Northern Gritstone to launch its first product next year
Silveray develops flexible digital X-ray detector technology using semiconductor inks, enabling new industrial and medical imaging applications that require curved or adaptable detector shapes.
Imperial spinout MintNeuro raises £1m to advance neural implants with semiconductor technology
MintNeuro develops compact semiconductor-based neural implants that reduce the invasiveness and power demands of traditional devices, supporting scalable neuromodulation treatments for conditions including epilepsy, Parkinson’s and dementia.
More venture news
- 19 Aug 2026
Prevalent AIPrevalent AI raises £16m from Integrity Growth Partners to turn fragmented enterprise data into a single view
EquityEnterprise - 17 Aug 2026
Versatile RobotXVersatile RobotX lands £1m led by British Design Fund to automate harvesting and crop handling with robotic systems
EquityAgriculture - 19 Aug 2026
EcoNomad SolutionsEcoNomad Solutions raises £400k in funding led by British Design Fund for small-farm waste-to-energy systems
EquityAgriculture
